GlassScriptPhysician profile
Jefferson John Cartwright
NPI 1285678300
$798.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $82.25 · 2021: $193 · 2022: $32.67 · 2023: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $319 · Food and Beverage: $25.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $319.26 |
| Food and Beverage | $25.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $319.26 | 2023 | Comprehensive Shoulder System, Taperloc, Persona |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.22 | 2019-2021 | |
| Genzyme Corporation | $72.73 | 2021-2023 | |
| Smith+Nephew, INC. | $69.73 | 2021 | |
| Djo, LLC | $34.41 | 2020 | |
| Integra Lifesciences Corporation | $31.95 | 2019-2020 | |
| Pacira Therapeutics, INC. | $30.54 | 2019-2021 | |
| Acera Surgical, INC. | $28.87 | 2019-2020 | |
| Bioventus LLC | $19.79 | 2021 | |
| Depuy Synthes Sales INC. | $19.69 | 2019 | |
| Kci USA, INC. | $17.37 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.26 | 2019 | |
| Bard Access Systems, INC. | $14.35 | 2019 | |
| Circassia INC. | $11.31 | 2019 | |
| Kinex Medical Company LLC | $9.61 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $4.34 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefferson Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.